Sarah Roberge, MPH

Sarah is currently an Institutional Biosafety Committee (IBC) Chair on the IBC team, working with research sites, sponsors, and CROs to ensure that human gene transfer clinical trials are conducted safely. Prior to joining WCG in early 2019, Sarah worked at Seattle Cancer Care Alliance, BloodworksNW, and the Benaroya Research Institute in a variety of roles, including serving as the main clinical research coordinator for a major genotyping study with over 10,000 patient samples.

Sarah received her BS in Biological Sciences from the University of Vermont in 2005 and her Master of Public Health (MPH) from the University of Washington in 2013. Sarah has been a collaborator on several peer-reviewed publications.